Huidagene Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
150
- Latest Deal Type
-
Later Stage VC
- Investors
-
7
Huidagene Therapeutics General Information
Description
Developer of gene therapy drugs designed for the treatments of rare human genetic diseases. The company specializes in the development and production of gene replacement and gene editing therapeutic products based on Adeno-Associated Virus technologies, providing sophisticated and reliable research and solutions for the treatment of various neurodegenerative diseases.
Contact Information
Website
www.cn.huidagene.comCorporate Office
- Unit 3, 6th Floor, Building 5
- Number 160, Basheng Road, Pudong New Area
- Shanghai, 200131
- China
Corporate Office
- Unit 3, 6th Floor, Building 5
- Number 160, Basheng Road, Pudong New Area
- Shanghai, 200131
- China
Huidagene Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-Mar-2026 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 12-May-2022 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 07-Sep-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 17-May-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 02-Dec-2019 | $14.2M | $18.6M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Nov-2018 | $4.34M | $4.34M | Completed | Generating Revenue |
Huidagene Therapeutics Comparisons
Industry
Financing
Details
Huidagene Therapeutics Competitors (29)
One of Huidagene Therapeutics’s 29 competitors is Genetix Biotherapeutics, a Private Equity-Backed company based in Somerville, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| EdiGene | Venture Capital-Backed | Beijing, China | ||||
| Belief BioMed | Venture Capital-Backed | Shanghai, China | ||||
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA |
Huidagene Therapeutics Signals
Huidagene Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HM Venture Partners | Venture Capital | Minority | ||
| Beijing Ruiyin Weiye Technology Development | Growth/Expansion | Minority | ||
| Kunnuo Tianqin Venture Capital | Corporate Venture Capital | Minority | ||
| GL Ventures | Venture Capital | Minority | ||
| HM Capital | Venture Capital | Minority |
Huidagene Therapeutics FAQs
-
When was Huidagene Therapeutics founded?
Huidagene Therapeutics was founded in 2018.
-
Where is Huidagene Therapeutics headquartered?
Huidagene Therapeutics is headquartered in Shanghai, China.
-
What is the size of Huidagene Therapeutics?
Huidagene Therapeutics has 150 total employees.
-
What industry is Huidagene Therapeutics in?
Huidagene Therapeutics’s primary industry is Drug Delivery.
-
Is Huidagene Therapeutics a private or public company?
Huidagene Therapeutics is a Private company.
-
What is Huidagene Therapeutics’s current revenue?
The current revenue for Huidagene Therapeutics is .
-
How much funding has Huidagene Therapeutics raised over time?
Huidagene Therapeutics has raised $80.4M.
-
Who are Huidagene Therapeutics’s investors?
HM Venture Partners, Beijing Ruiyin Weiye Technology Development, Kunnuo Tianqin Venture Capital, GL Ventures, and HM Capital are 5 of 7 investors who have invested in Huidagene Therapeutics.
-
Who are Huidagene Therapeutics’s competitors?
Genetix Biotherapeutics, EdiGene, Belief BioMed, CRISPR Therapeutics, and Sangamo Therapeutics are some of the 29 competitors of Huidagene Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process